Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1040.2000 -3.90 (-0.37%)
NSE Sep 08, 2025 15:31 PM
Volume: 415.8K
 

logo
Aurobindo Pharma Ltd.
29 Mar 2022
1040.20
-0.37%
buy
by BOB Capital Markets Ltd.
Target: 850
BOB Capital Markets Ltd.
ARBP acquired Veritaz Healthcare at 1x FY22E sales (9.8x EBITDA), marking its foray into domestic formulations
 
Aurobindo Pharma Ltd. is trading below all available SMAs
More from Aurobindo Pharma Ltd.
Recommended
IPOs this week: Seven upcoming listings, Urban Company plus ten new issues
| 08 Sep 2025, 05:30PM
Market closes higher, Ujjivan SFB plans to raise around Rs 2,000 crore via a QIP
Trendlyne Marketwatch | 08 Sep 2025, 03:59PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020